Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe

NCT03394209 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT03394209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03394209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe
Lead sponsor
Capital Medical University
Phase
Phase 2
Overall status
Completed
Start date
February 6, 2018
Completion date
March 27, 2019
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, influenza, influenza, human